Related Experiment Video

Updated: May 10, 2026

A Neonatal Imaging Model of Gram-Negative Bacterial Sepsis
08:46

A Neonatal Imaging Model of Gram-Negative Bacterial Sepsis

Published on: August 12, 2020

Pediatric Sepsis - Part I: "Children are not small adults!"

Derek S Wheeler1, Hector R Wong, Basilia Zingarelli

  • 1Division of Critical Care Medicine, Cincinnati Children's Hospital Medical Center, The Kindervelt Laboratory for Critical Care Medicine Research, Cincinnati Children's Research Foundation.

The Open Inflammation Journal
|June 1, 2013
PubMed

Insights

Pediatric sepsis presents unique challenges in critical care. Understanding developmental differences in host responses is crucial for effective treatment and reducing mortality in children.

Area of Science:

  • Pediatric critical care medicine
  • Infectious disease
  • Immunology

Background:

  • Sepsis is a leading cause of death globally, with increasing incidence.
  • Current sepsis therapies, based on adult models, have failed to significantly reduce pediatric mortality and morbidity.
  • Pediatric sepsis is distinct from adult sepsis due to key developmental differences in host response.

Purpose of the Study:

  • To review the critical differences in the pediatric host response to sepsis.
  • To highlight unique developmental variations at the organism, organ system, and cellular/molecular levels.
  • To underscore the need for targeted research in pediatric sepsis.

Main Methods:

  • Review of existing literature on pediatric sepsis.
  • Analysis of developmental differences in host response.
  • Comparison of pediatric and adult sepsis pathophysiology.

Main Results:

  • Significant developmental variations exist in pediatric sepsis.
  • Differences are observed at whole-organism, organ system, and cellular/molecular levels.
  • Current treatment paradigms require adaptation for pediatric populations.

Conclusions:

  • Pediatric sepsis requires a distinct understanding and approach compared to adult sepsis.
  • Further epidemiologic and mechanistic studies are essential for improved pediatric sepsis management.
  • Addressing developmental differences is key to advancing treatment and reducing adverse outcomes.

More Related Videos

A Controlled Mouse Model for Neonatal Polymicrobial Sepsis14:54

A Controlled Mouse Model for Neonatal Polymicrobial Sepsis

Published on: January 27, 2019

Design of Cecal Ligation and Puncture and Intranasal Infection Dual Model of Sepsis-Induced Immunosuppression07:30

Design of Cecal Ligation and Puncture and Intranasal Infection Dual Model of Sepsis-Induced Immunosuppression

Published on: June 15, 2019

Related Concept Videos

Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...